Merck & Co Inc XNYS: MRK

Strong Performer, Under Radar

83.36 -0.66 (-0.79%)

9.7M

XNYS Volume

XNYS 11 Jul, 2025 5:30 PM (EDT)

Acquisition

Merck to acquire Verona Pharma for $10 billion to expand its cardio-pulmonary pipeline & portfolio See details

Merck & Co Inc quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents